Mifepristone, involved in most abortions in the U.S., can now be distributed only in person and at clinics
“For the first time, FDA regulators will be able to see what’s happening in a clinical trial, looking at endpoints in the cloud as they occur,” writes FDA commissioner
A federal district court on Tuesday paused Louisiana’s lawsuit against the Food and Drug Administration’s liberalization of dispensing rules for the abortion pill mifepristone until the agency is able to complete a safety review, intensifying the conflict between anti-abortion Republicans and the Trump administration. Judge David Joseph of the Western District of Louisiana, who was […]
In today's Readout Newsletter, Denali and Corcept win FDA approvals, Sarepta eyes a rebound, and Allogene progresses with an off-the-shelf CAR-T
Colorado had banned therapy seeking to change the sexual orientation or gender identity of LGBTQ patients under 18. Over 20 US states and much of Europe, including Germany, have banned the practice
In this edition of STAT Health Tech: An AI chatbot for surgical patients got 'breakthrough' status from FDA, HHS phases out Claude, and more
A new study found GLP-1 drugs were associated with 50% fewer substance-related deaths, 39% fewer drug overdoses, and 26% fewer drug-related hospitalizations
President Donald Trump took executive action on Thursday to create the White House Great American Recovery Initiative in order to better coordinate the country’s national response to addiction. “Many of those with me today have personally known the heartache of a loved one taken by drug or alcohol addiction,” Trump told reporters in the Oval […]
FDA Commissioner Marty Makary said he believes “everything should be over the counter” unless a drug is unsafe, addictive or requires monitoring